AbL Diagnostics SA (ABLD) — Cash Flow Reinvestment Rate
AbL Diagnostics SA (ABLD) has a Cash Flow Reinvestment Rate of 0.84x as of June 2025, reinvesting €400.39K (capex €400.39K ) from operating cash flow of €479.46K. Explore AbL Diagnostics SA (ABLD) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AbL Diagnostics SA Cash Flow Reinvestment Rate (2017–2023)
Historical reinvestment intensity for AbL Diagnostics SA across 4 annual periods. Also explore AbL Diagnostics SA assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for AbL Diagnostics SA (2017–2023)
Year-by-year capital reinvestment analysis for AbL Diagnostics SA. For live market cap and broader valuation context, see how much is AbL Diagnostics SA worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.01x | €938.50K | €926.43K | €938.50K | — |
| 2020 | 0.00x | €0.00 | €29.51K | €0.00 | ▼ -100.0% |
| 2018 | 7.95x | €644.40K | €81.10K | €644.40K | ▲ +1658.8% |
| 2017 | 0.45x | €305.02K | €675.20K | €305.02K | — |